Literature DB >> 23806771

Adoptive transfer of umbilical cord blood-derived regulatory T cells and early viral reactivation.

Claudio G Brunstein, Bruce R Blazar, Jeffrey S Miller, Qing Cao, Keli L Hippen, David H McKenna, Julie Curtsinger, Philip B McGlave, John E Wagner.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23806771      PMCID： PMC3870093          DOI： 10.1016/j.bbmt.2013.06.004

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN： 1083-8791            Impact factor:   5.742


× No keyword cloud information.
  5 in total

1.  Non-parametric inference for cumulative incidence functions in competing risks studies.

Authors:  D Y Lin
Journal:  Stat Med       Date:  1997-04-30       Impact factor: 2.373

2.  Cytomegalovirus-specific T cells are primed early after cord blood transplant but fail to control virus in vivo.

Authors:  Suzanne M McGoldrick; Marie E Bleakley; Abraham Guerrero; Cameron J Turtle; Tori N Yamamoto; Shalini E Pereira; Colleen S Delaney; Stanley R Riddell
Journal:  Blood       Date:  2013-02-14       Impact factor: 22.113

3.  Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation.

Authors:  Mauro Di Ianni; Franca Falzetti; Alessandra Carotti; Adelmo Terenzi; Flora Castellino; Elisabetta Bonifacio; Beatrice Del Papa; Tiziana Zei; Roberta Iacucci Ostini; Debora Cecchini; Teresa Aloisi; Katia Perruccio; Loredana Ruggeri; Chiara Balucani; Antonio Pierini; Paolo Sportoletti; Cynthia Aristei; Brunangelo Falini; Yair Reisner; Andrea Velardi; Franco Aversa; Massimo F Martelli
Journal:  Blood       Date:  2011-02-03       Impact factor: 22.113

4.  Human herpesvirus 6 infection after hematopoietic cell transplantation: is routine surveillance necessary?

Authors:  Brian C Betts; Jo-Anne H Young; Celalettin Ustun; Qing Cao; Daniel J Weisdorf
Journal:  Biol Blood Marrow Transplant       Date:  2011-04-20       Impact factor: 5.742

5.  Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics.

Authors:  Claudio G Brunstein; Jeffrey S Miller; Qing Cao; David H McKenna; Keli L Hippen; Julie Curtsinger; Todd Defor; Bruce L Levine; Carl H June; Pablo Rubinstein; Philip B McGlave; Bruce R Blazar; John E Wagner
Journal:  Blood       Date:  2010-10-15       Impact factor: 22.113
  5 in total
  40 in total

1.  Engineered MBP-specific human Tregs ameliorate MOG-induced EAE through IL-2-triggered inhibition of effector T cells.

Authors:  Yong Chan Kim; Ai-Hong Zhang; Jeongheon Yoon; William E Culp; Jason R Lees; Kai W Wucherpfennig; David W Scott
Journal:  J Autoimmun       Date:  2018-05-30       Impact factor: 7.094

Review 2.  Adoptive immunotherapy with the use of regulatory T cells and virus-specific T cells derived from cord blood.

Authors:  Patrick J Hanley; Catherine M Bollard; Claudio G Brunstein
Journal:  Cytotherapy       Date:  2015-01-24       Impact factor: 5.414

3.  Towards antigen-specific Tregs for type 1 diabetes: Construction and functional assessment of pancreatic endocrine marker, HPi2-based chimeric antigen receptor.

Authors:  Ilian A Radichev; Jeongheon Yoon; David W Scott; Kurt Griffin; Alexei Y Savinov
Journal:  Cell Immunol       Date:  2020-09-30       Impact factor: 4.868

4.  FVIII-specific human chimeric antigen receptor T-regulatory cells suppress T- and B-cell responses to FVIII.

Authors:  Jeongheon Yoon; Anja Schmidt; Ai-Hong Zhang; Christoph Königs; Yong Chan Kim; David W Scott
Journal:  Blood       Date:  2016-11-15       Impact factor: 22.113

Review 5.  Mechanisms of Mixed Chimerism-Based Transplant Tolerance.

Authors:  Julien Zuber; Megan Sykes
Journal:  Trends Immunol       Date:  2017-08-18       Impact factor: 16.687

6.  Optimization of cGMP purification and expansion of umbilical cord blood-derived T-regulatory cells in support of first-in-human clinical trials.

Authors:  David H McKenna; Darin Sumstad; Diane M Kadidlo; Bjorn Batdorf; Colin J Lord; Sarah C Merkel; Christine M Koellner; Julie M Curtsinger; Carl H June; James L Riley; Bruce L Levine; Jeffrey S Miller; Claudio G Brunstein; John E Wagner; Bruce R Blazar; Keli L Hippen
Journal:  Cytotherapy       Date:  2016-11-22       Impact factor: 5.414

7.  Targeting Antigen-Specific B Cells Using Antigen-Expressing Transduced Regulatory T Cells.

Authors:  Ai-Hong Zhang; Jeongheon Yoon; Yong Chan Kim; David W Scott
Journal:  J Immunol       Date:  2018-07-18       Impact factor: 5.422

8.  Engineered ovalbumin-expressing regulatory T cells protect against anaphylaxis in ovalbumin-sensitized mice.

Authors:  Maha Abdeladhim; Ai-Hong Zhang; Laura E Kropp; Alyssa R Lindrose; Shivaprasad H Venkatesha; Edward Mitre; David W Scott
Journal:  Clin Immunol       Date:  2019-07-17       Impact factor: 3.969

Review 9.  Immune regulatory cell infusion for graft-versus-host disease prevention and therapy.

Authors:  Bruce R Blazar; Kelli P A MacDonald; Geoffrey R Hill
Journal:  Blood       Date:  2018-05-04       Impact factor: 22.113

10.  Alloantigen-specific regulatory T cells generated with a chimeric antigen receptor.

Authors:  Katherine G MacDonald; Romy E Hoeppli; Qing Huang; Jana Gillies; Dan S Luciani; Paul C Orban; Raewyn Broady; Megan K Levings
Journal:  J Clin Invest       Date:  2016-03-21       Impact factor: 14.808
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.